Trial Profile
Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 24 Dec 2019
Price :
$35
*
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Intermediate uveitis; Panuveitis; Posterior uveitis
- Focus Therapeutic Use
- Acronyms Iluvien
- 18 Dec 2019 Status changed from active, no longer recruiting to completed.
- 28 Mar 2018 According to an EyePoint Pharmaceuticals media release, pSivida Corp. changed its name to EyePoint Pharmaceuticals.
- 27 Apr 2017 Status changed from recruiting to active, no longer recruiting.